STOCK TITAN

EXEL (NASDAQ: EXEL) insider Dana T Aftab sells 29,873 shares for $1.32M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

EXEL reported an insider sale. Dana T Aftab sold 29,873 common shares on 02/19/2026 for $1,324,867.55. The filing also lists prior issuances of performance shares and restricted stock with dated grants: 20,006 (01/11/2024), 6,385 (08/15/2023), 8,757 (05/15/2023), and 12,770 (09/06/2023).

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did EXEL insider Dana T Aftab sell in the Form 144?

Dana T Aftab sold 29,873 common shares on 02/19/2026, as reported in the Form 144 filing. The sale generated proceeds of $1,324,867.55, per the disclosed transaction.

How much cash did the insider sale for EXEL generate?

The disclosed sale produced $1,324,867.55 in gross proceeds. This figure is listed alongside the 29,873 common shares sold on 02/19/2026 in the filing excerpt.

Does the filing show recent equity grants for EXEL insiders?

Yes; the excerpt lists recent grants: 20,006 performance shares (01/11/2024), 6,385 performance shares (08/15/2023), 8,757 restricted stock (05/15/2023), and 12,770 performance shares (09/06/2023).

When was the insider sale by Dana T Aftab executed?

The Form 144 shows the sale date as 02/19/2026. The filing pairs that date with the sale quantity of 29,873 common shares and proceeds of $1,324,867.55.
Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.43B
253.13M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA